News

Equinor ASA Enhances Employee Share Program with Buy-Backs

Equinor ASA Enhances Employee Share Program with Buy-Backs

Equinor ASA's Latest Buy-Back Program Explained

Equinor ASA is making headlines with its newly announced buy-back program dedicated to supporting share-based incentive programs for its employees and management. This strategic move is aimed at enhancing employee engagement and maintaining a robust incentive structure within the company.

Details of the Buy-Back Program

The buy-back program was officially announced on February 7, 2024, adding a new layer to Equinor's commitment to its workforce. The duration of this initiative runs from February 15, 2024, to January 15, 2025, allowing the company ample time to execute its buying strategy.

Financial Overview

Equinor ASA has set aside a substantial budget for this program, amounting to NOK 1,774,000,000. The company aims to acquire a maximum of 16,800,000 shares, with specific targets for different periods within the buy-back window. Initially, up to 7,400,000 shares can be acquired until May 15, 2024, followed by an additional 9,400,000 shares in the latter half of the program.

Progress Updates

As of January 15, 2025, Equinor ASA purchased a total of 522,506 shares on the Oslo Stock Exchange. The average purchase price for these shares was NOK 288.9915. This transaction contributes to the overall buy-back efforts and reflects the company’s proactive approach in managing its equity structure.

Summary of Share Transactions

To provide a clearer picture, here’s a brief overview of transactions completed under this buy-back program:

  • Date: January 15, 2025
  • Shares Acquired: 522,506
  • Average Price: NOK 288.9915
  • Total Value: NOK 150,999,793

Additionally, previously reported buy-backs accumulated a total of 5,804,350 shares with an average price of NOK 279.6176. This emphasizes Equinor’s aggressive stance on repurchasing shares as part of their ongoing commitments. Cumulatively, under this buy-back program, 6,326,856 shares have been secured, reinforcing the company's strategic objectives.

Shareholding Impact and Future Outlook

Following these transactions, Equinor ASA now holds 70,665,908 of its own shares, equating to 2.53% of the total share capital. This ownership includes shares obtained from prior buy-back initiatives, all intended to bolster employee incentives and potentially reduce the issued share capital in the future.

Market Regulation Compliance

This public release of information aligns with the EU Market Abuse Regulation requirements and complies with Section 5-12 of the Norwegian Securities Trading Act.

Contact Information for Investors and Media

For additional inquiries, interested parties can reach out to Equinor's investor relations:

Bård Glad Pedersen, Senior Vice President, Investor Relations
+47 918 01791

Sissel Rinde, Vice President, Media Relations
+47 412 60 584

Frequently Asked Questions

What is the purpose of Equinor ASA's buy-back program?

The buy-back program aims to support share-based incentive plans for employees and management, enhancing engagement and retention.

When was the buy-back program announced?

The announcement was made on February 7, 2024, marking an important step for employee incentives.

What is the total budget for the buy-back program?

Equinor ASA has allocated NOK 1,774,000,000 for this buy-back program.

How many shares can Equinor acquire during this period?

The maximum shares to be acquired is 16,800,000 shares, divided into two phases during the buy-back period.

What percentage of Equinor's share capital is currently owned by the company?

Equinor ASA currently holds 2.53% of its share capital, amounting to 70,665,908 shares.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Cutting-Edge Innovations from GrowGeneration at Cultivate'25

Updated Category News Views 135

Exciting Innovations at Cultivate'25 GrowGeneration Corp. (NASDAQ: GRWG), a leading name in hydroponic retail, is gearing up to demonstrate its cutting-edge products at Cultivate'25. This premier horticulture trade show is a golden opportunity for lawn and garden professionals, greenhouses, and nurseries to witness firsthand the innovations that are transforming...

Continue Reading
Cellectar Biosciences Showcases Breakthrough Cancer Treatment Data

Updated Category News Views 153

Innovative Cancer Treatment Presentation by Cellectar Biosciences Cellectar Biosciences, Inc. (NASDAQ: CLRB), a pioneering biopharmaceutical entity, is making waves in the field of oncology with its recent presentation at a renowned cancer research conference. The company announced its positive preclinical data for CLR 121225, showcasing its potential as a groundbreaking...

Continue Reading
Fidelity National Financial's Strategic $500 Million Notes Offering

Updated Category News Views 58

Fidelity National Financial Secures $500 Million in Senior Notes Fidelity National Financial (NYSE: FNF), a prominent player in title insurance and transaction services, has made waves with the recent announcement of a successful public offering of $500 million in senior notes via its subsidiary, F&G Annuities & Life, Inc. This strategic move is poised to bolster the...

Continue Reading
Centering Healthcare Institute Gains Investment to Enhance Care Model

Updated Category News Views 65

Centering Healthcare Institute Secures $7.6 Million Investment Centering Healthcare Institute (CHI) has announced an exciting new chapter in its mission to enhance healthcare delivery with a recent investment of $7.6 million from The Studio @ Blue Meridian. This significant funding will allow CHI to implement a strategic three-year plan focused on scaling its services and...

Continue Reading
Leadership Changes at Ring Energy: New CFO Transition Strategy

Updated Category News Views 275

Ring Energy's Recent Leadership Transition Ring Energy, Inc. has recently made headlines with the announcement of a significant shift in its leadership. The company has confirmed that Travis T. Thomas, the former Chief Financial Officer (CFO), has resigned from his position to pursue new opportunities. This transition marks an important moment for the organization and...

Continue Reading